Axsome Therapeutics Inc

Manager, Quality Assurance – GxP Auditing (GMP-GDP) - Remote

United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Position Overview

  • Location Type:
  • Job Type: Full time
  • Salary:

PTC Therapeutics is a global commercial biopharmaceutical company dedicated to extending life’s moments for children and adults living with rare diseases. We foster an inclusive culture where everyone feels valued, respected, and empowered.

Job Description Summary

The Manager, Quality Assurance – GxP Auditing (GMP-GDP) is responsible for executing GxP Quality Assurance (QA) auditing functions, with a focus on Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) quality systems governing compliance programs for commercial and clinical activities. This role involves collaboration with internal cross-functional teams to evaluate CMC processes, procedures, and activities for adherence to industry standards, regulatory guidelines, and company SOPs. The incumbent will contribute to the continuous improvement of a risk-based audit program, qualification requirements, and the inspection management process. Additionally, the role supports and/or conducts internal and external GMP and GDP compliance audits of Contract Manufacturing Organizations (CMOs), vendors, laboratories, and submission documents, and assists in inspection readiness and QA activities.

Responsibilities

  • Contributes to the execution of the PTC GMP/GDP audit strategy to maintain compliance with applicable regulations, guidelines, and current regulatory requirements.
  • Performs assigned internal and external audits to assure compliance with GMP and GDP regulations.
  • Evaluates the quality systems of CMOs, laboratories, and other vendors.
  • Ensures alignment on resolution strategies and champions corrective actions until fully implemented.
  • Performs inspection readiness activities and visits to ensure preparedness for regulatory authority review.
  • Schedules, plans, and notifies auditees of upcoming audits in accordance with audit plans.
  • Conducts audits and prepares and submits audit reports for review.
  • Communicates audit results to stakeholders.
  • Assesses audit responses and collaborates with CMC colleagues and QA supervision to develop and ensure closure of CAPA plans.
  • Assists with GxP inspection readiness activities for regulatory authority inspections and coordinates tracking of document requests, responses, and supporting documentation during inspections.
  • Contributes to PTC’s understanding of worldwide regulations, guidelines, and GxP practices to meet regulatory compliance and corporate business requirements.
  • Maintains working knowledge of current FDA, EU, and other global regulations and guidance governing GMP and GDP activities.
  • Applies global regulations, agency guidelines, and internal procedures to assure compliance.
  • Supports Quality Management System (QMS) implementation and Operations efforts involving GMP audit activities.
  • Contributes to QA review of SOPs and documentation related to audit functions and other related documents as required.
  • Contributes to GMP/GDP audit related metrics.
  • Assists in identifying and communicating CMC risks.

Requirements

  • Maintains working knowledge of current FDA, EU and other global regulation and guidance governing Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) activities.
  • Applies global regulation, agency guidelines and internal procedures to assure compliance.
  • Contributes to QA review of SOPs and documentation related to audit functions, as well as other related documents as required by regulation and as appropriate.
  • Contributes to GMP/GDP audit related metrics.
  • Assists in identifying and communicating CMC risks.

Company Information

PTC Therapeutics is a global commercial biopharmaceutical company with a commitment to extending life’s moments for children and adults living with a rare disease. We cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.

Visit our website to learn more about our company and culture! Site: www.ptcbio.com

Skills

GxP Auditing
GMP
GDP
Quality Systems
Regulatory Compliance
SOP Development
Risk-Based Audit
Inspection Readiness
CMC Processes
Vendor Qualification

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI